VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $807,300 | -10.6% | 30,000 | 0.0% | 0.35% | -1.9% |
| Q2 2023 | $903,300 | -6.9% | 30,000 | 0.0% | 0.36% | -9.8% |
| Q1 2023 | $970,500 | +12.9% | 30,000 | 0.0% | 0.40% | +16.0% |
| Q4 2022 | $859,800 | +18.8% | 30,000 | 0.0% | 0.34% | +18.7% |
| Q3 2022 | $724,000 | -11.8% | 30,000 | 0.0% | 0.29% | +3.6% |
| Q2 2022 | $821,000 | -28.7% | 30,000 | 0.0% | 0.28% | -28.1% |
| Q1 2022 | $1,151,000 | +19.8% | 30,000 | 0.0% | 0.39% | +14.1% |
| Q4 2021 | $961,000 | -3.2% | 30,000 | 0.0% | 0.34% | +28.3% |
| Q3 2021 | $993,000 | -3.4% | 30,000 | 0.0% | 0.26% | -3.6% |
| Q2 2021 | $1,028,000 | -5.6% | 30,000 | -1.4% | 0.28% | +11.3% |
| Q1 2021 | $1,089,000 | – | 30,412 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |